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Introduction Case Reports 
An infected prosthetic graft of the aorta is still among 
the most unwelcome and challenging complications 
that the vascular surgeon has to tackle. Despite being 
uncommon, the reported incidence ranging from 1 to 
6%, aortic prosthetic graft infections invariably portend 
high mortality and significant risk of limb loss. 
The conventional pproach comprises total excision 
of the infected prosthetic graft, oversewing of the 
aortic stump and lower-limb revascularisation by ex- 
tra-anatomic bypass. Although recent series show that 
this management has improved mortality and mor- 
bidity rates, it remains far from ideal. ~-7 
When knowledge of the natural history of graft 
infections was scarce, conservative management used 
to be the procedure of choice. It has now been largely 
abandoned due to unsatisfactory results. Yet in selected 
cases, notably patients with high surgical risks, a con- 
servative approach may still be a valid option. Con- 
servative treatment consists of surgical debridement, 
drainage, and local antibiotic or povidone-iodine ir- 
rigation, with complete graft preservation orotherwise 
percutaneous computed tomography (CT)-guided 
drainage with local and systemic antibiotic therapy. 
In specific circumstances both strategies yield en- 
couraging results, s-x5 
In this study we have evaluated the few published 
reports and our own experience with patients treated 
conservatively for infected aortic prosthetic grafts. Our 
aim was to determine whether conservative treatment 
should be reserved for patients at high operative risk 
or might be a useful initial therapeutic approach for 
all patients. 
* Please address all correspondence to: G. R. Pistolese, Department 
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Case 1 
A 76-year-old man with a rectal carcinoma underwent 
elective resection of a symptomatic aortoiliac an- 
eurysm in August 1989. The aorta was reconstructed by
inserting a knitted Dacron bifurcated graft extending 
from the infrarenal aorta to the right external iliac 
artery and to the left common femoral artery, under 
systemic antibiotic coverage (cefotaxime 2g i.v. and 
vancomycin 500 mg i.v. on induction of anaesthesia). 
Recovery was uneventful. One month later the patient 
was readmitted for treatment of the rectal tumour. He 
had no symptoms or signs of aortic graft infection. At 
operation a perigraft fluid collection was noted. After 
evacuation of the fluid and povidone-iodine irrigation 
two drainage tubes were placed along the graft. The 
rectum was resected (Hartmann procedure). Initial 
cultures isolated a pure growth of Enterobacter cloacae 
and the patient received treatment with i.v. piperacillin 
(3 g three times daily), amikacin (500 mg every 12 h) 
and metronidazole (500 mg three times daily). Anti- 
biotic solution (gentamycin) was instilled through the 
drainage tubes until the effluent became sterile. After 
a 24-day course of drainage with local and systemic 
antibiotic treatment the patient was discharged on a 
regimen of oral systemic antibiotic therapy (ofloxacin). 
He remained asymptomatic for 2 years before dying 
of non graft-related causes. 
Case 2 
In April 1994 a 76-year-old man underwent elective 
repair of an abdominal aortoiliac aneurysm and re- 
construction with a knitted Dacron bifurcated graft, 
under systemic antibiotic overage (cefotaxime 2 g i.v. 
and vancomycin 500mg i.v. on induction of an- 
aesthesia). Postoperative recovery was uneventful. 
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Fig. 1. (Case 3) Sump drain catheter placed percutaneously into the 
periprosthetic fluid collection. 
Three weeks after discharge the patient was readmitted 
because of fever (up to 39 °C), malaise, pain in the left 
iliac fossa and acute abdominal symptoms. Laboratory 
findings on admission included leukocytosis (12 800) 
and an erythrocyte sedimentation rate of 115 mm/h. 
An ultrasound scan showed a fluid collection in the 
left iliac fossa and a CT scan documented a large 
abscess (maximum diameter 10 cm) surrounding the 
left iliac graft limb and the psoas muscle. Exploratory 
laparotomy showed a perigraft fluid collection. The 
fluid was drained and two irrigation tubes were in- 
serted along the graft. Cultures of purulent material 
isolated Escherichia coil The graft was irrigated with 
antibiotic solution (cefotaxime) injected through the 
drainage tubes and the patient received concomitant 
antibiotic therapy with i.v. amikacin (500 mg twice 
daily) and cefotaxime (2 g three times daily). Drainage 
tubes were removed 20 days later, when the effluent 
became sterile and CT-scan showed no perigraft fluid 
collection. The patient was discharged on a regimen 
of oral antibiotic therapy (ciprofloxacin), which he 
continued for 3 months. A follow-up CT-scan 18 
months after surgery revealed no further signs of graft 
infection. 
Fig. 2. (Case 3) Follow-up CT scan after 42 months: absence of signs 
of recurrent graft infection. 
Fig. 3. (Case 4) CT scan documented a retroperitoneal fluid collection 
around the graft, 
Case 3 
A 68-year-old man underwent elective repair of an 
abdominal aortic aneurysm, under systemic antibiotic 
coverage (cefotaxime 2 g i.v. and vancomycin 500 mg 
i.v. on induction of anaesthesia), in July 1992. The aorta 
was reconstructed using a straight knitted Dacron graft 
with the proximal anastomosis just below the renal 
arteries. No postoperative complications occurred. 
Two months later the patient was readmitted because 
of intermittent-remittent fever and tachycardia of 2 
Fig. 4. (Case 4) Follow-up CT scan after 8 months from CT-guided 
percutaneous drainage: absence of signs of recurrent graft infection. 
days' duration. Temperature was 38°C, white cell 
blood count was 12000 and he had an increased 
erythrocyte sedimentation rate. The abdomen was 
non-tender and femoral pulses were present bi- 
laterally. Real-time ultrasound of the pelvis showed a 
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fluid collection around the graft and a CT scan of 
the abdomen and pelvis showed a non-homogeneous 
retroperitoneal fluid collection, surrounding the entire 
graft from the proximal anastomosis to the aortic 
bifurcation. A leukocyte-labelled technetium 99-m hex- 
ametazime scan showed increased radiotracer uptake 
in the graft region. Because of the foreseeable t chnical 
difficulty in undertaking a conventional operation 
(proximal anastomosis just below the origin of the 
renal arteries) we began CT-guided percutaneous 
drainage. Initial cultures of the aspirate (60cm 3) 
showed a pure growth of Staphylococcus epidermidis. 
Antibiotic solution (rifampicin) was injected through 
the drainage tube, around the graft. After a 3-week 
course of drainage and irrigation, two consecutive 
cultures yielded negative results and the drainage 
tube was removed. The patient was discharged on a 
regimen of oral antibiotic therapy (600 mg clindamycin 
daily), which he continued for 6 months. Follow-up 
CT scans 1 and 3 months after drainage showed no 
perigraft fluid collections. The last follow-up CT scan, 
at 42 months, still showed nothing abnormal around 
the aortic graft. 
Case 4 
An 81-year-old man, with heart disease, bilateral 
chronic arteriopathy and diverticulosis, underwent 
elective repair of an abdominal aortic aneurysm (max- 
imum diameter 8 cm) in June 1994, with a knitted 
Dacron bifurcated graft extending from the infrarenal 
aorta to the bilateral common iliac arteries. The oper- 
ation was performed under systemic antibiotic cov- 
erage (cefotaxime 2 g i.v. and vancomycin 500 mg i.v. 
on induction of anaesthesia). The patient had an un- 
eventful postoperative course. Three weeks after dis- 
charge he had to be admitted urgently because of 
fever, vomiting, and a tender swelling in the left iliac 
fossa. Laboratory findings included a white cell blood 
count of 20 000 and an increased erythrocyte sedi- 
mentation rate. ACT scan showed evidence of a fluid 
collection around the aortic bifurcation and the left 
psoas muscle. The patient received amikacin (500 mg 
i.v. every 12h) and cefotaxime (2 g i.v. three times 
daily). CT-guided percutaneous drainage yielded 
1200 ml of purulent material. Cultures grew Escherichia 
coil Antibiotic solution (cefotaxime in sterile saline) 
was infused through the drainage catheter. Local anti- 
biotic therapy was continued for 21 days, two cultures 
resulted sterile and drainage was removed. A follow- 
up CT scan showed that the perigraft fluid had dis- 
appeared. On postoperative day 23 the patient was 
discharged from the hospital and continued taking 
oral antibiotic (500 mg ampicillin daily). He remained 
asymptomatic for 10 months when he died suddenly 
of liver failure. Post-mortem examination showed no 
evidence of prosthetic graft infection. 
Discussion 
Conventional treatment of aortic graft infection con- 
sists of total graft excision and revascularisation, as
graft excision alone is rarely feasible. This treatment 
option has become the "gold standard" in the man- 
agement of aortic graft infection, but results remain 
far from ideal. 6"7'~6 Yet its critics emphasise the risk of 
aortic stump dehiscence, the risk of re-infection of the 
extra-anatomic bypass used for revascularisation, and 
its poor long-term patency. 2'3'~7 As alternative ap- 
proaches to conventional management in certain well- 
defined circumstances, many recent reports re- 
commend in situ replacement or conservative treat- 
ment. 14'18-2° In situ reconstruction avoids the poten- 
tial risk of aortic stump blow-out and results in a 
lower incidence of limb loss. Its main drawback is 
the risk of severe complications owing to recurrent 
infection.5,19,21, 22
Reports published in the 1960s and 1970s commonly 
described patients with aortic graft infections treated 
conservatively. Surgeons' reluctance to remove in- 
fected prostheses in the absence of overwhelming 
indications reflected their concern that removing a 
functioning raft could result in severe distal ischaemia 
and even limb loss. At that time methods for extra- 
anatomic reconstruction around the infected sites had 
not been well developed. 23Because it resulted in un- 
satisfactory mortality and reinfection rates, con- 
servative treatment eventually became reserved almost 
exclusively for patients considered at high risk for 
conventional surgery. 
Nevertheless, a deeper analysis of such results - in 
cases with complications and in those without them 
- allows the identification of a group of patients who 
may benefit from conservative treatment. Support for 
the importance of secondary complications in surgical 
failure came from our review of published reports of 
patients with aortic grafts treated conservatively (Table 
1). In patients with graft-enteric erosions, fistula, bleed- 
ing or pseudoaneurysms, in terms of operative mor- 
tality (76.6%) or persisting infections eventually 
necessitating radical surgery (6.4%), conservative treat- 
ment achieved wholly unacceptable r sults. During 
postoperative follow-up ranging from 2 to 24 months, 
only 17% of the 94 patients described could reasonably 
Eur J Vasc Endovasc Surg Vol 14 Supplement A, December 1997 
50 G.R. Pistolese et aL 
Table 1. Conservative treatment of aortic graft infection: difference 
of results in presence of secondary complications. Literature 
review. 
No Excis. 
patients Recovery treat. Mortality 
Cases of aortic graft 
infection with 
complications* 94 1_7% 6.4% 76.6% 
Cases of aortic graft 
infection without 
complications-t 43 65.1% 23.3% 18.6% 
*Sharf'59, Hagland'59, MGH'59, Boyd'59, Cordell'60, Thistle- 
waite'60, Pollock'61, Deweese'62, Javid'62, Long'62, Humpries'63, 
Ferris'65, Van De Water'65, Wiernan'66, Donovan'67, Sheill'69, Sch- 
ramel'71, Szilagyi'72, Tobias'73, Elliot'74, Brenner'74, Ray'76, 
Becker'76, Buchbinder'80, Perdue'80, Puglia'80, Puppala'80, O'M- 
ara'81, O'Hara'86, Thomas'86, Higgins'90. 
t Van De Water'65, Conn'70, Szilagyi'72, Bouhoutsos'74, Chris- 
tenson'77, Liekweg'77, Craw ford'77, Yashar'78, Knight'83, 
Almgren'85, Edwards'88, Francois'91, Wakefield'94, Morris'94. 
consider themselves cured. 21"24-54 Patients without sec- 
ondary complications fared better. Of the 43 patients 
considered, with follow-up ranging from 21 to 61 
months, 65.1% recovered without complications and 
23.3% had reinfections that responded to conventional 
treatment. Overall mortality, including patients in 
whom persisting infections necessitated further sur- 
gery, reached 18.6%. 8'9'13'14'37'42'5542 
Our review and personal experience suggests that, 
whereas patients with secondary complications un- 
doubtedly need conventional treatment, patients with- 
out secondary complications - - not only those at high 
surgical r isk- could undergo conservative procedures. 
The contraindications to conservative management 
include anastomotic omplications, systemic sepsis, 
septic peripheral embolisation (a sign of severe bac- 
terial colonisation of the graft) and all immune system 
disorders. 63 Patients with uncomplicated graft in- 
fections without general or local contraindications 
seem to respond well to an initial conservative ap- 
proach using percutaneous CT-guided or ultrasound- 
guided drainage with concomitant high-dose local 
and systemic antibiotic therapy. More frequent use of 
conservative treatment might lead to earlier diagnosis 
of infections, before secondary complications develop. 
CT-guided percutaneous drainage is a relatively 
simple procedure. It is done under local anaesthesia 
and is far less traumatic for the patient han surgical 
drainage. After an initial scan to assess the ideal punc- 
ture site and patient's position, a 12-French dual- 
lumen catheter (Van Sonnemberg type) is inserted 
percutaneously. The cavity is drained and, as long as 
the catheter emains in place, samples of drainage 
fluid are repeatedly cultured to isolate organisms for 
antibiotic susceptibility testing. An antibiotic solution 
is instilled locally into the cavity through the catheter 
once or more a day. 12 Drainage catheters are left in 
place until the drain yields sterile fluid and CT scans no 
longer show a retroperitoneal fluid collection. Systemic 
antibiotic therapy, selected from susceptibility testing, 
is administered intravenously for 4-6 weeks; after this 
period patients must continue long-term oral antibiotic 
therapy (from 3 months to life-long). 
Although CT-guided drainage is relatively widely 
used in clinical practice, especially in diagnosis, few 
published reports have addressed its therapeutic uses. 
Tobin reported one patient in whom an aortofemoral 
bypass graft infection developed i month after surgery 
and responded to CT-guided percutaneous drainage. 1°
Matley et al. also described one patient who had a 
thoracoabdominal aortic graft infection with a good 
outcome after conservative management. 12 Svensson 
noted the diagnostic and therapeutic usefulness of 
percutaneous catheter drainage in patients with aortic 
graft infections at high operative risk for redo surgery. 15 
Hollier also recommended this approach as a valid 
alternative to conventional treatment in selected 
patients. 64 
As well as being indicated in high surgical risk 
patients, we believe that CT-guided percutaneous 
drainage can be used as a first step in treating aortic 
graft infection provided that infection is diagnosed 
early, before complications have developed. CT-guided 
drainage is indicated only for infections caused by less 
virulent organisms with high sensitivity to antibiotic 
therapy and is contraindicated in all patients with 
immune system impairment. 
Conclusions 
At present he preferred treatment of aortic graft in- 
fection is tota l  prosthetic graft excision, with lower 
limb revascularisation achieved by an extra-anatomic 
bypass through uninfected tissue planes. Conservative 
treatment by surgical drainage is an alternative ap- 
proach, but is a compromise solution that has few 
advantages. In high surgical risk patients without 
complications, CT-guided percutaneous drainage may 
be a safer alternative than routine aggressive excision. 
It also helps diagnosis by allowing detection of the 
graft infection in bacteriological cultures and antibiotic 
sensitivity testing. We suggest hat it be used as the 
initial approach in all patients, who have an early 
diagnosis of aortic graft infections without com- 
plications. It offers a good chance of recovery or im- 
provement by reducing bacterial concentrations before 
planning graft excision. Future experience will verify 
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the real value of percutaneous catheter treatment as a 
first step for managing patients with non-complicated 
aortic graft infections. 
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